Počet záznamov: 1
antineoplastiká hormonálne
SYS d018931 LBL 00000cz--a2200000n--4500 005 20250606214624.2 008 950526|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 065 $a D27.505.954.248.169 066 $a 01 $c 03 150 $a antineoplastiká hormonálne $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a Hormonal Antineoplastic Agents $2 eng 450 $w v $a látky antineoplastické hormonálne $2 slo 450 $w v $a látky protinádorové hormonálne $2 slo 550 $7 sllk_us_auth*d009376 $Y Neoplasms, Hormone-Dependent $w b $a nádory hormonálne závislé 665 $a 96 $2 eng 665 $a Antineoplastic Agents (1966-1995) $2 eng 680 9-
$i Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) $2 eng 680 $a consider also NEOPLASMS, HORMONE-DEPENDENT /drug ther $2 eng 750 -2
$a Antineoplastic Agents, Hormonal $2 eng 980 $x M
Počet záznamov: 1